Kazakhstan's TB Cases Fall 9.9% in 2025, Deaths Down 10%

According to Kazakhstan's Ministry of Health, tuberculosis incidence in the country fell by a further 9.9% in 2025, and mortality dropped by 10%. The ministry attributes the result to modern diagnostics, effective medicines, and the guarantee that treatment is available to all citizens.

The issues were discussed at an international conference in Almaty, attended by experts from Kazakhstan, Uzbekistan, Kyrgyzstan, Georgia and other countries in the region.

Kazakhstan is expanding the use of shortened treatment regimens. For drug-resistant tuberculosis, the country is introducing six-month regimens without injections, including BPaL and BPaLM. They are shorter than traditional courses and easier for patients to tolerate. In the future, treatment courses could be shortened further. The international "1×1×1" strategy aims to treat latent TB infection in one day, active TB in one month, and to make new methods available within a year of approval. To prepare, countries need to develop diagnostics, update clinical protocols and train regulators.